SCHEMBL8678772

SCHEMBL8678772

CCOc1cccc(-c2nc(C)ccc2-c2ccc(OC)cc2)c1N1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.42
MAPK14 Q16539 2/20 0.42
TGFBR1 P36897 1/20 0.42
KMT2A Q03164 4/20 0.41
SYK P43405 3/20 0.40
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE10A Q9Y233 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
HTT P42858 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
PKM P14618 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8677612 0.99 ADORA3 (0.41) ADORA3MAPK14TGFBR1KMT2ASYK
SCHEMBL8677205 0.92 PRKDC (0.45) ADORA3MAPK14TGFBR1KMT2ALMNA
SCHEMBL8827923 0.89 ALDH1A1 (0.40) MAPK14TGFBR1KMT2ALMNAMAPT
SCHEMBL8675940 0.89 ALDH1A1 (0.43) ADORA3KMT2ALMNAMAPTKDM4E
SCHEMBL8827939 0.88 ALDH1A1 (0.40) MAPK14TGFBR1KMT2ALMNAMAPT
SCHEMBL8676997 0.87 ALDH1A1 (0.43) ADORA3KMT2ALMNAMAPTKDM4E
SCHEMBL8677539 0.85 MAPT (0.43) ADORA3KMT2ASYKLMNAMAPT
SCHEMBL8677811 0.83 ADORA3 (0.43) ADORA3MAPK14TGFBR1KMT2ASYK
SCHEMBL8827935 0.82 MEN1 (0.39) KMT2ALMNAMAPTKDM4ESMN1; SMN2
SCHEMBL8827914 0.79 ALDH1A1 (0.38) KMT2ALMNAMAPTSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750708-A Pyridine compounds intermediates processes compositions and methods ELI LILLY AND COMPANY (US) 1998-05-12 US disclosed
US-5672609-A POSTMENOPAUSAL SYNDROME; ANTILIPEMIC AND -CARCINOGENIC AGENTS; OSTEOPOROSIS; CARDIOTONIC AGENTS; RESTENOSIS; SIDE EFFECT REDUCTION COMPARED TO ESTROGEN ELI LILLY AND COMPANY (US) 1997-09-30 US disclosed